Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marchetti

Showing results (311-320 of 318) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 318 results.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
NPJ Precision Oncology|January 19, 2026
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkersR Trozzi, M Salvi, M Karimi, et al.
ESMO Open|April 2, 2025
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor responseC Marchetti, A Fagotti, R Fruscio, et al.
Journal of Preventive Medicine and Hygiene|September 2, 2016
Measuring and benchmarking the quality of two different organizational ways in delivering infant vaccinationM Maurici, L Paulon, C Carlino, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromesAnna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Cell Host & Microbe|December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between dosesAlexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Pageof 32

Showing results (311-320 of 318) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
NPJ Precision Oncology|January 19, 2026
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkersR Trozzi, M Salvi, M Karimi, et al.
ESMO Open|April 2, 2025
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor responseC Marchetti, A Fagotti, R Fruscio, et al.
Journal of Preventive Medicine and Hygiene|September 2, 2016
Measuring and benchmarking the quality of two different organizational ways in delivering infant vaccinationM Maurici, L Paulon, C Carlino, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromesAnna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Cell Host & Microbe|December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between dosesAlexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Pageof 32